Register Login
Register to leave comments
  • News bot July 30, 2026, 8:30 p.m.

    📋 VERACYTE, INC. (VCYT) - Financial Results

    Filing Date: 2026-07-30

    Accepted: 2026-07-30 16:18:32

    Event Type: Financial Results

    Event Details:

    VERACYTE, INC. (VCYT) Reports the reporting period Financial Results VERACYTE, INC. (VCYT) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 25509
    • Net Income: 44330
    • EPS: 0.54
    • Cash and equivalents: 301187
      • Launched the Prosigna Breast Test in the U.S. for patients diagnosed with early
      • receptor positive (HR+) breast cancer.
      • Launched the TrueMRD Monitoring Test for patients with muscle

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Other Income Net 6.52K 10.87K $-4.35K -40.04%
    Current Assets Prepaid Expenses Other Current Assets 12.71K 10.28K $2.43K +23.63%
    Current Assets Property Equipment Net 21.93K 22.19K $-259.00 -1.17%
    Current Assets Intangible Assets Net 82.70K 89.15K $-6.45K -7.23%
    Current Assets Other Assets 2.98K 902.00 $2.07K +229.82%
    Current Liabilities Accounts Payable 8.02K 8.02K $0.00 +0.00%
    Current Liabilities Accrued Liabilities 47.68K 48.80K $-1.12K -2.30%
    Changes In Operating Assets And Liabilities Prepaid Expenses Other Current Assets -2.43K -5.46K $3.03K +55.51%
    Changes In Operating Assets And Liabilities Other Assets -451.00 540.00 $-991.00 -183.52%
    Changes In Operating Assets And Liabilities Operating Lease Liabilities 453.00 -1.19K $1.64K +138.20%
    Changes In Operating Assets And Liabilities Accounts Payable 3.76K 3.11K $645.00 +20.72%

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VERACYTE, INC.
    • Ticker Symbol: VCYT

Search

News categories